Search

Displaying results 7861 - 7870 of 10000 in total
  1. Drug

    2G7

    go.drugbank.com/drugs/DB18589
    Experimental

    2G7 is an anti-TGF-beta monoclonal antibody developed by Genentech.

  2. Drug

    Dilanubicel

    go.drugbank.com/drugs/DB18722
    Investigational

    Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells.

  3. Drug

    RO-4987655

    go.drugbank.com/drugs/DB12933
    Investigational

    RO4987655 has been used in trials studying the treatment of Neoplasms.

  4. Drug

    Nimustine

    go.drugbank.com/drugs/DB13069
    Investigational

    Nimustine has been used in trials studying the treatment of Glioblastoma.

  5. Drug

    Tribenoside

    go.drugbank.com/drugs/DB13227
    Investigational

    Anti-inflammatory agent used in edema of extremities, varicose veins & phlebitis.

  6. Drug

    Tropatepine

    go.drugbank.com/drugs/DB13252
    Experimental

    Tropatepine has been used in France for its antiparkinsons activities [A175024].

  7. Drug

    R-306465

    go.drugbank.com/drugs/DB12382
    Investigational

    R306465 has been used in trials studying the treatment of Neoplasms.

  8. Drug

    Camicinal

    go.drugbank.com/drugs/DB12567
    Investigational

    Camicinal has been used in trials studying the treatment of Gastroparesis.

  9. Drug

    Renzapride

    go.drugbank.com/drugs/DB04917
    Investigational

    Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). … It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.

  10. Drug

    D-fluoromethyltyrosine F-18

    go.drugbank.com/drugs/DB15296
    Investigational

    D-fluoromethyltyrosine F-18 is under investigation in clinical trial NCT01089998 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety … , Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations).